# Integrating Emotional Stress and Lipid Lowering in Cardiovascular Disease Management: The Future of Precision Cardiovascular Prevention

## TL;DR

This paper argues that emotional stress plays a key role in cardiovascular disease, suggesting that managing both stress and lipids can better reduce risk.

## Contribution

The paper introduces the Emotion–Lipid Synergy Model and advocates for precision psychocardiology in cardiovascular prevention.

## Key findings

- Emotional stress contributes to atherosclerotic disease and acute events, even with low LDL-C and apoB levels.
- Women and patients with angina but no obstructive coronary disease are more vulnerable to mental-stress ischemia.
- Integrating emotion assessment with lipid control could reduce residual cardiovascular risk.

## Abstract

Residual cardiovascular risk remains substantial despite widespread adoption of intensive lipid-lowering strategies—statins, PCSK9 inhibitors, and RNA-based agents—that achieve very low LDL-C and apoB levels. Over the past three years, converging epidemiologic and mechanistic evidence has highlighted emotional stress—including anger, grief, anxiety, and chronic psychosocial strain—as a biologically active determinant of atherosclerotic disease and a frequent trigger of acute events. We propose the Emotion–Lipid Synergy Model, in which lipid burden establishes the atherothrombotic substrate while emotion-driven autonomic and vascular perturbations amplify endothelial dysfunction, microvascular constriction, inflammation, and thrombogenicity—thereby widening the residual-risk gap even when lipid targets are met. From this perspective, prevention should evolve toward precision psychocardiology: systematically screening for distress and stress reactivity; leveraging wearables to detect high-risk emotional states; and delivering timely, scalable, just-in-time behavioral interventions alongside guideline-directed lipid management. Particular attention is warranted for women and patients with angina and no obstructive coronary disease, who appear disproportionately susceptible to mental-stress ischemia. We outline a research agenda—flagship outcomes trials, mechanistic studies, and multimodal phenotyping—and discuss implementation pathways that integrate emotion metrics into cardiac rehabilitation and routine care. Integrating emotion assessment and modulation with lipid control offers a pragmatic route to reduce residual risk and advance equitable, personalized cardiovascular prevention.